Smith+Nephew gets FDA clearance for new hip surgery system

Smith+Nephew earned 501(k) clearance from the FDA for its Catalystem Primary Hip System.

Advertisement

The system aims to tackle the changing needs and demands of primary hip surgery, including the expanding role of ambulatory surgery centers in hip procedures, according to a July 16 news release. 

The Catalystem system is designed to be effective for direct anterior approach, which is becoming more common.

The direct anterior approach is a less invasive surgery, leading to improved range of motion and faster recovery times, the release said.

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Orthopedic

Advertisement

Comments are closed.